Cap with vent plug for biological fluid collection device

By using a ventilation plug in the cap of the biological fluid collection device, allowing air to pass and preventing blood samples from passing, the problem of difficulty in air discharge in the prior art is solved, the complete collection of blood samples and the reduction of analyte deviation is achieved, and the The quality and accuracy of the sample.

CN119073980APending Publication Date: 2024-12-06BECTON DICKINSON & CO
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411405289.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2018-05-01
Filing Date
2019-04-30
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

Existing biological fluid collection devices are difficult to effectively discharge air in sealed chambers, resulting in only a small part of the available volume when collecting blood samples, affecting the accuracy and non-biasability of the samples, especially during blood gas measurement and anticoagulation. .

Method used

A cap with a ventilation plug is designed that allows air to pass and prevents blood samples from passing through, by reducing the contact area between blood and carboxymethylcellulose additive or increasing the path length, or in carboxymethylcellulose Porous material is introduced in front of the additive plug, reducing diffusion rate, thereby limiting analyte deviation.

Benefits of technology

It effectively prevents the escape of blood samples, ensures the complete collection of samples, reduces analyte bias, especially in a small number of blood samples, significantly reduces the impact of ion concentration, and improves the quality of blood samples.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119073980A_ABST
    Figure CN119073980A_ABST
Patent Text Reader

Abstract

A cap with a vent plug for a biological fluid collection device is disclosed. The vent plug permits passage of air therethrough and prevents passage of a blood sample therethrough. In one embodiment, the vent plug is a porous plug. In one embodiment, the cap includes a vent plug containing a carboxymethyl cellulose additive. Also disclosed is a cap that limits analyte deviations due to interaction of plasma ions with carboxymethyl cellulose by reducing the contact area between the blood and the carboxymethyl cellulose additive, such as reducing the radius.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] Description of the case

[0002] This patent application is a divisional patent application.

[0003] The original application of this divisional patent application (i.e., the parent case, office file number IIM206269) is a patent application with an international application date of April 30, 2019, an international application number of PCT / US2019 / 029926, a Chinese national application number of 201980037568.1, and a subject name of "Cap with vent plug for a biological fluid collection device".

[0004] Cross-references to related applications

[0005] This application claims priority to U.S. Provisional Application Serial No. 62 / 665,092, filed on May 1, 2018, entitled “Cap with Venting Plug for Biological Fluid Collection Device,” the entire disclosure of which is incorporated herein by reference in its entirety. Technical Field

[0006] The present disclosure generally relates to a biological fluid collection device and more particularly to a cap with a vent plug for a biological fluid collection device. Background Art

[0007] A cap is required to seal the collection chamber of a biological fluid collection device. The collection chamber needs to be purged of air prior to sealing the fluid within the chamber. One of the key applications of such a cap is to seal the biological fluid collection device after the residual air in the system has been removed. This has two major effects on sample collection. First, blood must be collected anaerobically (without air) for blood gas measurements. Second, the removal of air facilitates the collection of the entire sample volume, rather than only a small portion of the available volume due to the presence of air pockets. Both of these effects are critical for properly anticoagulated and unbiased blood samples. Summary of the invention

[0008] The present disclosure provides a cap with a vent plug for a biological fluid collection device. The vent plug allows air to pass through it and prevents blood sample from passing through it. In one embodiment, the vent plug is a porous plug. In one embodiment, the cap includes a vent plug containing a carboxymethyl cellulose additive.

[0009] In one embodiment, the present disclosure provides a cap that limits analyte deviation (or analyte shift) caused by the interaction of plasma ions with carboxymethyl cellulose by reducing the contact area between blood and carboxymethyl cellulose additive, such as reducing the radius. In one embodiment, the present disclosure provides a cap that limits analyte deviation caused by the interaction of plasma ions with carboxymethyl cellulose by increasing the path length between blood and carboxymethyl cellulose additive, such as increasing a certain path length. In one embodiment, the present disclosure provides a cap that reduces the diffusion rate by introducing a porous material in front of the carboxymethyl cellulose additive plug, thereby limiting analyte deviation caused by the interaction of plasma ions with carboxymethyl cellulose.

[0010] According to one embodiment of the present invention, a cap for a biological fluid collection device includes a cap body, which defines a first chamber having a first diameter, a second chamber having a second diameter, and a third chamber having a third diameter, the second chamber being between the first chamber and the third chamber; and a vent plug arranged in the third chamber, the vent plug containing a carboxymethyl cellulose additive, wherein the second diameter is smaller than the first diameter, and wherein the second diameter is smaller than the third diameter.

[0011] In one configuration, the vent plug allows air to pass therethrough and prevents a blood sample from passing therethrough. In another configuration, the vent plug is a porous plug. In yet another configuration, the first diameter is smaller than the third diameter. In one configuration, the first diameter is 1.016 mm, the second diameter is 0.4 mm, and the third diameter is 1.5 mm. In another configuration, the length of the second chamber is 1.6 mm, and the length of the third chamber is 3.5 mm. In yet another configuration, the cap body has a front end and a rear end. In one configuration, the first chamber is adjacent to the front end of the cap body. In another configuration, the third chamber is adjacent to the rear end of the cap body. In yet another configuration, the cap body includes a flange portion and a plug portion.

[0012] According to another embodiment of the present invention, a cap for a biological fluid collection device includes a cap body, which defines a chamber having a first diameter, the cap body having a front end and a rear end; a first vent plug arranged in the chamber; and a second vent plug containing a carboxymethyl cellulose additive, wherein the first vent plug is arranged between the second vent plug and the front end of the cap body.

[0013] In one configuration, the second vent plug allows air to pass therethrough and prevents the blood sample from passing therethrough. In another configuration, the second vent plug is a porous plug. In yet another configuration, the first vent plug is a porous plug. In one configuration, the second vent plug is disposed in the chamber. In another configuration, the second vent plug is a sheet covering a portion of the rear end of the cap body. In yet another configuration, the cap body includes a flange portion and a plug portion. BRIEF DESCRIPTION OF THE DRAWINGS

[0014] The above and other features and advantages of the present disclosure and the manner in which they are achieved will become more apparent, and the present disclosure itself will be better understood, by referring to the following description of embodiments of the present disclosure understood in conjunction with the accompanying drawings, in which:

[0015] Figure 1 is a perspective view of a biological fluid collection device with a cap according to one embodiment of the present invention.

[0016] Figure 2 is a perspective view of a biological fluid collection device with a cap according to one embodiment of the present invention.

[0017] Figure 3 is a perspective view of a cap according to an embodiment of the present invention.

[0018] Figure 4 is a cross-sectional view of a cap according to an embodiment of the present invention.

[0019] Figure 5 is a cross-sectional view of a cap with a vent plug according to an embodiment of the present invention.

[0020] Figure 6 is a perspective view of a cap according to another embodiment of the present invention.

[0021] Figure 7 According to an embodiment of the present invention Figure 6 A graph of the caps, showing unit deviation.

[0022] Figure 8 is a perspective view of a cap according to another embodiment of the present invention.

[0023] Fig. 9 According to an embodiment of the present invention Figure 8 A graph of the caps, showing unit deviation.

[0024] Fig.10 is a cross-sectional view of a cap with a vent plug according to another embodiment of the present invention.

[0025] Fig.11 is a cross-sectional view of a cap with a vent plug according to another embodiment of the present invention.

[0026] Fig.12 is a cross-sectional view of a cap with a vent plug according to another embodiment of the present invention.

[0027] Fig.13 is a cross-sectional view of a cap with a vent plug according to another embodiment of the present invention.

[0028] Fig.14is a perspective view of a biological fluid collection device having a collection module disposed within an outer housing according to one embodiment of the present invention.

[0029] Fig.15 According to an embodiment of the present invention Fig.14 A partially cut-away perspective view of a biological fluid collection device.

[0030] Fig.16 is a perspective view of a biological fluid collection device having a collection module disposed within an outer housing according to one embodiment of the present invention.

[0031] Fig.17 According to an embodiment of the present invention Fig.16 A partially cut-away perspective view of a biological fluid collection device.

[0032] Fig.18A is a partially cut-away perspective view of a biological fluid collection device inserted into a tube holder in accordance with one embodiment of the present invention.

[0033] Fig.18B is a partially cut-away perspective view of a biological fluid collection device according to one embodiment of the present invention, wherein a biological fluid sample flows into a collection module through a tube holder.

[0034] Fig.18C is a partially cut-away perspective view of a biological fluid collection device removed from a tube holder in accordance with one embodiment of the present invention.

[0035] Fig.18D is a partially cut-away perspective view of a collection module of a biological fluid collection device removed from an outer housing in accordance with one embodiment of the present invention.

[0036] Fig.18E is a partially cut-away perspective view of a cap removed from a collection module of a biological fluid collection device in accordance with one embodiment of the present invention.

[0037] Fig.18F is a partially cut-away perspective view of an activation member of a collection module of a biological fluid collection device according to one embodiment of the present invention, the activation member being activated to dispense biological fluid from the collection module.

[0038] Fig.19 is a partial perspective view of a lower end of a biological fluid collection device having a biological fluid collection module disposed within an external collection housing in accordance with one embodiment of the present invention.

[0039] Fig. 20 is a partially cut-away perspective view of a lower end of a biological fluid collection device according to one embodiment of the present invention.

[0040] Fig.21 is a perspective view of a biological fluid collection device according to one embodiment of the present invention.

[0041] Corresponding reference characters indicate corresponding parts throughout the several views.The exemplifications set out herein illustrate exemplary embodiments of the disclosure and these exemplifications should not be construed as limiting the scope of the disclosure in any way. DETAILED DESCRIPTION

[0042] The following description is provided to enable those skilled in the art to make and use the contemplated described embodiments to implement the present invention. However, various modifications, equivalents, variations and substitutes remain apparent to those skilled in the art. Any and all such modifications, variations, equivalents and substitutes should fall within the spirit and scope of the present invention.

[0043] For the purposes of the following description, the terms "upper", "lower", "right", "left", "vertical", "horizontal", "top", "bottom", "lateral", "longitudinal" and their derivatives shall relate to the present invention as oriented in the accompanying drawings. However, it should be understood that the present invention may adopt various alternative variations unless expressly stated to the contrary. It should also be understood that the specific devices shown in the drawings and described in the following specification are merely illustrative embodiments of the present invention. Therefore, specific dimensions and other physical characteristics related to the embodiments disclosed herein should not be considered limiting.

[0044] The present disclosure provides a cap with a vent plug for a biological fluid collection device. The vent plug allows air to pass through it and prevents blood sample from passing through it. In one embodiment, the vent plug is a porous plug. In one embodiment, the cap includes a vent plug containing a carboxymethyl cellulose additive.

[0045] Carboxymethylcellulose is a "self-sealing" additive that swells when it comes in contact with liquid. When this additive is placed in a porous material (particularly a hydrophobic material), it allows air to escape before swelling shut when the liquid reaches the carboxymethylcellulose. This prevents liquid from escaping the collection chamber of the biological fluid collection device. Carboxymethylcellulose can cause analyte bias (usually Ca) in small blood samples (<5 mL). 2+ 、Na + , K + ).

[0046] If a membrane with carboxymethylcellulose additive is exposed to blood or related fluids, it can significantly bias results for analytes in blood at high surface area contact area to volume ratios. Ion exchange between the carboxymethylcellulose additive and ions in plasma can lead to erroneous results.

[0047] In one embodiment, the cap of the present disclosure limits analyte bias due to the interaction of plasma ions with carboxymethyl cellulose by reducing the contact area between blood and the carboxymethyl cellulose additive, such as reducing the radius.

[0048] In one embodiment, the cap of the present disclosure limits analyte bias due to interaction of plasma ions with carboxymethyl cellulose by increasing the path length between the blood and the carboxymethyl cellulose additive, such as by a certain path length.

[0049] In one embodiment, the cap of the present disclosure reduces the diffusion rate by introducing a porous material in front of the carboxymethyl cellulose additive plug, thereby limiting analyte bias due to the interaction of plasma ions with the carboxymethyl cellulose.

[0050] The cap of the present disclosure reduces the rate at which deflected ions may travel away from the carboxymethylcellulose source into the blood (ie, the measurement sample). The cap of the present disclosure is particularly interesting in small volumes of blood (<5 ml), where carboxymethylcellulose additives can significantly affect ion concentrations.

[0051] The present disclosure provides a cap with a vent plug for a biological fluid collection device. Figure 14-21 As shown, the cap of the present disclosure is compatible with the biological fluid collection device 1 .

[0052] refer to Fig.14 and 15 In one embodiment, the biological fluid collection device 1 includes a collection module 10 disposed within an outer housing 34. The collection module 10 is adapted to receive a biological fluid sample, such as a blood sample, and includes a housing 12, a closure 14, a mixing chamber 16, a holding chamber 18, a cap 20, and an activation member 22.

[0053] In one embodiment, the housing 12 includes a first end 24, a second end 26, and a passage 28 extending between the first end and the second end and providing fluid communication between the first end 24 and the second end 26 of the housing 12. The passage 28 has a sample introduction opening 30 at the first end 24 of the housing 12 and a sample dispensing opening 32 at the second end 26 of the housing 12. The mixing chamber 16 and the holding chamber 18 are arranged to be in fluid communication with the passage 28. The mixing chamber 16 and the holding chamber 18 are positioned so that a biological fluid sample (e.g., a blood sample) introduced into the sample introduction opening 30 of the passage 28 will first pass through the mixing chamber 16, then enter the holding chamber 18, and then reach the sample dispensing opening 32 of the passage 28. In this way, the blood sample can be mixed with an anticoagulant or other additive provided in the mixing chamber 16, and then the stabilized sample is received and stored in the holding chamber 18.

[0054] The mixing chamber 16 allows passive mixing of the blood sample with an anticoagulant or another additive (e.g., a blood stabilizer) as the blood sample flows through the passage 28. The interior of the mixing chamber 16 may have any suitable structure or form, as long as it provides mixing of the blood sample with an anticoagulant or another additive as the blood sample passes through the passage 28. The mixing chamber 16 may include a dry anticoagulant, such as heparin or EDTA, deposited on or within the mixing chamber 16. The mixing chamber 16 may, for example, include an open-cell foam containing a dry anticoagulant dispersed within the pores of the open-cell foam to promote circulation mixing and effectiveness of anticoagulant absorption.

[0055] The open cell foam may be treated with an anticoagulant to form a dry anticoagulant powder finely distributed in the pores of the open cell foam. When a blood sample enters the mixing chamber 16, the blood sample passes through the open cell foam and is exposed to the anticoagulant powder distributed throughout the internal pore structure of the open cell foam.

[0056] The open-cell foam may be a soft, deformable open-cell foam that is inert to blood, such as a melamine foam, such as Basotect available from BASF. ® The foam may be composed of a formaldehyde-melamine-sodium bisulfite copolymer. The open-cell foam may also be a flexible hydrophilic open-cell foam that is substantially heat-resistant and resistant to organic solvents. In one embodiment, the foam may include a sponge material.

[0057] Anticoagulants or other additives may be introduced into open cell foams by soaking the foam in a liquid solution of the additive and water and then evaporating the water to form a dry additive powder that is finely distributed throughout the internal structure of the foam.

[0058] After passing through the mixing chamber 16, the blood sample can be directed to the holding chamber 18. The holding chamber 18 can take any suitable shape and size to store a sufficient volume of blood required for the desired test, such as 500 microliters (μl) or less. In one embodiment, the holding chamber 18 is defined by a portion of the housing 12 in combination with an elastic sleeve 40 fixed around the exterior of the housing 12. The elastic sleeve 40 can be made of any material that is flexible, deformable and capable of providing a fluid-tight seal with the housing 12, including but not limited to natural or synthetic rubber and other suitable elastic materials. The housing 12 includes a recess 42 extending from the exterior of the housing 12 to the passage 28, effectively forming an opening in the housing 12 that is fluidly connected to the passage 28. The elastic sleeve 40 covers the recess 42 that defines the holding chamber 18, and the holding chamber 18 has an internal fill volume of 500 μl or less.

[0059] The cap 20 disposed at the second end 26 of the housing 12 covers the sample dispensing opening 32 of the passage 28. Figure 1-5The cap 20 of the present disclosure includes a vent plug 44 that allows air to pass therethrough and prevents the blood sample from passing therethrough. In one embodiment, the vent plug 44 is a porous plug. In one embodiment, the cap 20 includes a vent plug 44 that includes a carboxymethyl cellulose additive.

[0060] refer to Fig.15 In one embodiment, the cap 20 includes a vent plug 44, such as a porous plug, extending from the inner surface of the cap 20 to the outer surface of the cap 20. The vent plug 44 is constructed to allow air to pass through the cap 20 while preventing the blood sample from passing through the cap 20, and may include a hydrophobic filter. The vent plug 44 has a selected air passage resistance that can be used to finely control the filling rate of the passage 28. By changing the porosity of the plug, the speed of air flowing out of the cap 20 can be controlled, thereby controlling the speed at which the blood sample flows into the collection module 10. If the blood sample flows into the collection module 10 too quickly, hemolysis may occur. If the blood sample flows into the collection module 10 too slowly, the sample collection time may be too long.

[0061] The closure 14 is engaged with the first end 24 of the housing 12 to seal the passage 28. The closure 14 allows the introduction of a blood sample into the passage 28 of the housing 12 and may include a pierceable self-sealing stopper 36 having an outer shield 38, such as Hemogard available from Becton, Dickinson and Company. TM The closure 14 is also secured to an outer housing 34, which may be a vacuum-containing blood collection tube, such as the Vacutainer available from Becton, Dickinson and Company. ® Blood collection tube.

[0062] The cap 20 disposed at the second end 26 of the housing 12 may also include a flange 46 to assist a user in removing the cap 20 from the housing 12. Fig.15 As shown, the outer diameter of the flange 46 can be smaller than the inner diameter of the outer housing 34 in which the collection module 10 can be placed. Fig.19 and 20 As shown, the outer diameter of the flange 46 can be substantially equal to the inner diameter of the outer shell 34. In this configuration, the flange 46 can include a recess or slot 48 extending from the upper surface to the lower surface to allow the vacuum within the outer shell 34 to bypass the flange 46. Fig.19 and 20As shown, the flange 46 can be made of an optically transparent material and can have a raised outer diameter surface so that it can magnify the vent plug 44 area of ​​the cap 20, allowing medical personnel to see when the blood sample has completely filled the passage 28 and reached the cap 20. The flange 46 can also engage with a recessed portion of the inner wall of the outer shell 34 to constrain the cap 20 therein.

[0063] In use, the needle cannula 50 ( Fig.18A and 18C ) is inserted into the passage 28 of the housing 12 through the sample introduction opening 30, for example, through the pierceable self-sealing stopper 36 of the closure 14. Fig.18A As shown, the combined collection module 10 and outer housing 34 may be inserted into a conventional tube holder 52 having a cannula through which the biological fluid passes.

[0064] Through the outer shell 34 ( Fig.18B ), the biological fluid sample is drawn from the conventional tube holder 52 into the passageway 28 of the housing 12. The blood sample fills the entire passageway 28 by first entering the mixing chamber 16 and then the holding chamber 18, and any air present in the passageway 28 is expelled into the outer housing 34. As described above, the biological fluid sample is exposed to and mixed with the anticoagulant or other additives while passing through the mixing chamber 16. When the passageway 28, mixing chamber 16, and holding chamber 18 of the collection module 10 have been completely filled, the cap 20 stops the collection of the blood sample. The vent plug 44 of the cap 20 prevents blood from entering the outer housing 34.

[0065] Once sample collection is complete, the outer housing 34 including the collection module 10 is separated from the tube holder 52 ( Fig.18C ), then separating the outer shell 34 from the collecting module 10 by removing the closure 14 still attached to the collecting module 10 from the outer shell 34 ( Fig.18D ). Removal of the closure 14 can be accomplished by a user grasping the outer shield 38 and outer housing 34 of the closure 14 and pulling or twisting them in opposite directions.

[0066] Once the collection module 10 is separated from the outer shell 34, the cap 20 can then be removed from the collection module 10 ( Fig.18E ), exposing the second end 26 of the housing 12. Removal can be accomplished by a user grasping the flange 46 and pulling the cap 20 from the housing 12. After the cap 20 is removed, the blood sample is retained within the passage 28 of the housing 12 by capillary action. Alternatively, removal of the cap 20 can occur when the collection module 10 is removed from the outer housing 34. In this configuration, the cap 20 is restrained within the outer housing 34 by the interaction of the flange 46 with a corresponding recess of the outer housing wall. In one embodiment, the cap 20 can be connected to the outer housing 34 so that the outer housing 34 and the cap 20 are removed in one step.

[0067] The blood sample is then dispensed from the collection module 10 by activation of the activation member 22, for example by applying inward pressure in the direction of the arrow on the portion of the elastic sleeve 40 covering the holding chamber 18, forcing the blood sample out of the holding chamber 18 and through the sample dispensing opening 32 ( Fig.18F ). In this way, the blood sample can be transferred to a device intended to analyze the sample, such as a point-of-care testing device, such as a cartridge tester or via a port, while minimizing exposure of medical personnel to the blood sample.

[0068] Although a portion of the resilient sleeve 40 is shown and described as partially defining the holding chamber 18 and acting as the activation member 22 for dispensing the blood sample from the collection module 10, it is contemplated that other alternative arrangements for achieving the same results may be used. For example, the holding chamber 18 may be completely defined by the housing 12, and a separate activation device (including but not limited to a plunger, button, slider, etc.) engaged with the holding chamber 18 may be activated to dispense the blood sample.

[0069] exist Fig.16 and 17 In another embodiment shown, the closure member 14 may have a Luer lock connector 54 that passes through the obstruction member 36. This configuration is useful when drawing a blood sample from an artery, where a vacuum is not required to draw the blood sample into the collection module 100 ( Fig.16 and 17 ), venous blood collection requires a vacuum. Collection module 100 is used in the same manner as collection module 10, except that Luer lock connector 54 is used to connect collection module 100 to a wing assembly or other collection component with a matching Luer lock connector to introduce a blood sample into passageway 28.

[0070] The collection module 10, 100 may also be used without the outer housing 34. In the case of the collection module 10, a syringe or other power source may be used to draw the sample into the collection module 10. Furthermore, while the discussion herein focuses on using the collection module 10, 100 to collect a blood sample and mix it with an anticoagulant or other additive, the collection module 10, 100 may also be used to collect any liquid sample, such as other bodily fluids, or may be used to provide mixing and dispensing of a sample that has been collected by other means.

[0071] In another configuration, the collection module 10 may include labels 56a, 56b adhered to the closure 14 and the outer shell 34 that must be broken to remove the collection module 10 from the outer shell 34. Figure 14-17As shown, the label 56a may be a strip that extends only along a portion of the periphery of the closure 14 and the outer shell 34. Twisting the closure 14 relative to the outer shell 34 will cause the strip to break at the location where the strip transitions from the outer shell 34 to the closure 14. Perforations 58 may be provided in the label 56a at the location where it transitions from the outer shell 34 to the closure 14 to assist in breaking the strip when the closure 14 is twisted. Alternatively, as shown in FIG. Fig.21 As shown, the label 56b may surround the entire perimeter of the closure 14 and the outer shell 34. At the location where the label 56b transitions from the outer shell 34 to the closure 14, a perforation 58 is provided in the label 56b, forming a band 60 surrounding the closure 14, which can be separated from the portion of the label 56b surrounding the outer shell 34. Removing the band 60 from the closure 14 allows the closure 14 to be removed from the outer shell 34. A pull tab 62 may be provided on the band 60 to facilitate separation thereof from the portion of the label 56b surrounding the outer shell 34.

[0072] As discussed above, refer to Figure 1-5 The cap 20 of the present disclosure includes a vent plug 44 that allows air to pass therethrough and prevents the blood sample from passing therethrough. In one embodiment, the vent plug 44 is a porous plug. In one embodiment, the cap 20 includes a vent plug 44 that includes a carboxymethyl cellulose additive.

[0073] The cap of the present disclosure is compatible with any collection chamber of a biological fluid collection device, and the cap of the present disclosure can be used to evacuate air before sealing the liquid within the chamber. Figure 14-18F The cap of the present disclosure is also compatible with the biological fluid collection device shown. Figure 1 and 2 The biological fluid collection device shown is compatible. In addition, the cap of the present disclosure is also compatible with other biological fluid collection devices having a collection chamber.

[0074] Carboxymethylcellulose is a "self-sealing" additive that swells when it comes in contact with liquid. When this additive is placed in a porous material (particularly a hydrophobic material), it allows air to escape before swelling shut when the liquid reaches the carboxymethylcellulose. This prevents liquid from escaping the collection chamber of the biological fluid collection device. Carboxymethylcellulose can cause analyte bias (usually Ca) in small blood samples (<5 mL). 2+ 、Na + , K + ).

[0075] If a membrane with carboxymethylcellulose additive is exposed to blood or related fluids, it can significantly bias results for analytes in blood at high surface area contact area to volume ratios. Ion exchange between the carboxymethylcellulose additive and ions in plasma can lead to erroneous results.

[0076] In one embodiment, the cap 20 of the present disclosure limits analyte bias due to the interaction of plasma ions with carboxymethyl cellulose by reducing the contact area between blood and the carboxymethyl cellulose additive, such as reducing the radius.

[0077] In one embodiment, the cap 20 of the present disclosure limits analyte bias due to the interaction of plasma ions with carboxymethyl cellulose by increasing the path length between the blood and the carboxymethyl cellulose additive, such as by a certain path length.

[0078] In one embodiment, the cap 20 of the present disclosure reduces the diffusion rate by introducing a porous material in front of the carboxymethyl cellulose additive plug, thereby limiting analyte bias due to the interaction of plasma ions with the carboxymethyl cellulose.

[0079] The cap 20 of the present disclosure reduces the rate at which deflected ions can enter the blood, ie, the measurement sample, from the carboxymethylcellulose source. The cap 20 of the present disclosure is particularly useful in small volumes of blood (<5 ml), where carboxymethylcellulose additives may significantly affect ion concentrations.

[0080] refer to Figure 1-5 , the cap 20 includes a cap body 70 and a vent plug 44. In one embodiment, the cap body 70 defines a first chamber 72 having a first diameter D1, a second chamber 74 having a second diameter D2, and a third chamber 76 having a third diameter D3. In one embodiment, the second chamber 74 is located between the first chamber 72 and the third chamber 76. In one embodiment, the second diameter D2 is smaller than the first diameter D1. In one embodiment, the second diameter D2 is smaller than the third diameter D3. In one embodiment, the first diameter D1 is smaller than the third diameter D3. In one embodiment, the first diameter D1 is 1.016 mm, the second diameter D2 is 0.4 mm, and the third diameter D3 is 1.5 mm. In one embodiment, the length of the second chamber 74 is 1.6 mm, and the length of the third chamber 76 is 3.5 mm.

[0081] By reducing the diameter of the second chamber 74, the cap 20 of the present disclosure limits analyte shift due to the interaction of plasma ions with the carboxymethylcellulose by reducing the contact area between the blood and the carboxymethylcellulose additive, eg, reducing the radius.

[0082] In one embodiment, the vent plug 44 is disposed in the third chamber 76. In one embodiment, the vent plug 44 includes a carboxymethyl cellulose additive. The vent plug 44 allows air to pass therethrough and prevents the blood sample from passing therethrough. In one embodiment, the vent plug 44 is a porous plug. The vent plug 44 is constructed to allow air to pass through the cap 20 while preventing the blood sample from passing through the cap 20, and may include a hydrophobic filter. The vent plug 44 has a selected air passage resistance that can be used to finely control the filling rate of the passage 28. By changing the porosity of the plug, the speed of the air flowing out of the cap 20 can be controlled, thereby controlling the speed at which the blood sample flows into the collection module 10.

[0083] refer to Figure 4 and 5 In one embodiment, the cap body 70 has a front end 80 and a rear end 82 . In one embodiment, the first cavity 72 is adjacent to the front end 80 of the cap body 70 , and the third cavity 76 is adjacent to the rear end 82 of the cap body 70 .

[0084] In one embodiment, the cap body 70 includes a flange portion 84 and a plug portion 86. The flange portion 84 can be used to help a user remove the cap 20 from the housing 12. Figure 1 and 2 As shown, the outer diameter of the flange portion 84 can be greater than the inner diameter of the outer housing 34 in which the collection module 10 can be placed. Alternatively, the flange portion 84 can have an outer diameter that is substantially equal to or less than the inner diameter of the outer housing 34. Fig.19 and 20 As shown, the flange 46, 84 can be made of an optically transparent material and can have a raised outer diameter surface so that it can magnify the vent plug 44 area of ​​the cap 20, allowing medical personnel to see when the blood sample has completely filled the passage 28 and reached the cap 20. The flange 46, 84 can also engage with a recessed portion of the inner wall of the outer shell 34 to constrain the cap 20 therein.

[0085] In another embodiment, referring to Fig.11 and 12 , the cap 120 of the present disclosure includes a first vent plug 122 and a second vent plug 124, and the second vent plug 124 includes a carboxymethyl cellulose additive.

[0086] Carboxymethylcellulose is a "self-sealing" additive that swells when it comes in contact with liquid. When this additive is placed in a porous material (particularly a hydrophobic material), it allows air to escape before swelling shut when the liquid reaches the carboxymethylcellulose. This prevents liquid from escaping the collection chamber of the biological fluid collection device. Carboxymethylcellulose can cause analyte shifts (usually Ca) in small blood samples (<5 mL). 2+ 、Na + , K+ ).

[0087] If a membrane with carboxymethylcellulose additive is exposed to blood or related fluids, the high surface area contact area to volume ratio can significantly affect the bias results for analytes in blood. Ion exchange between the carboxymethylcellulose additive and ions in plasma can lead to erroneous results.

[0088] In one embodiment, the cap 120 of the present disclosure reduces the diffusion rate by introducing a porous material in front of the carboxymethyl cellulose additive plug, thereby limiting analyte bias due to the interaction of plasma ions with the carboxymethyl cellulose.

[0089] The cap 120 of the present disclosure reduces the rate at which deflected ions may travel away from the carboxymethylcellulose source into the blood (ie, the measurement sample). The cap 120 of the present disclosure is particularly useful in small amounts of blood (<5 ml), where the carboxymethylcellulose additive may significantly affect ion concentrations.

[0090] refer to Fig.11 and 12 , the cap 120 includes a cap body 170, a first vent plug 122 and a second vent plug 124. In one embodiment, the cap body 170 defines a chamber 172 having a first diameter D1. The cap body 170 includes a front end 180 and a rear end 182. In one embodiment, the chamber 172 extends from the front end 180 to the rear end 182.

[0091] In one embodiment, the cap body 170 includes a flange portion 184 and a plug portion 186. The flange portion 184 can be used to help the user remove the cap 20 from the housing 12. Fig.11 and 12 As shown, the flange portion 184 may have an outer diameter substantially equal to the inner diameter of the outer shell 34. Fig.19 and 20 As shown, the flange 46, 184 can be made of an optically transparent material and can have a raised outer diameter surface so that it can magnify the vent plug area of ​​the cap 120, allowing the physician to see when the blood sample has completely filled the passage 28 and reached the cap 120. The flange 46, 184 can also engage with a groove of the inner wall of the outer shell 34 to constrain the cap 120 therein.

[0092] In one embodiment, the first vent plug 122 is disposed in the chamber 172. In one embodiment, the second vent plug 124 includes a carboxymethyl cellulose additive. In one embodiment, the first vent plug 122 is disposed between the second vent plug 124 and the front end 180 of the cap body 170.

[0093] The second vent plug 124 allows air to pass therethrough and prevents the blood sample from passing therethrough. In one embodiment, the first vent plug 122 is a porous plug. In one embodiment, the second vent plug 124 is a porous plug.

[0094] The second vent plug 124 is constructed to allow air to pass through the cap 120 while preventing the blood sample from passing through the cap 120, and may include a hydrophobic filter. The second vent plug 124 has a selected resistance to air passage, which can be used to finely control the filling rate of the passage 28. By changing the porosity of the plug, the speed of air flowing out of the cap 120 can be controlled, thereby controlling the speed of the blood sample flowing into the collection module 10.

[0095] refer to Fig.11 In one embodiment, the second vent plug 124 is a sheet 190 that covers a portion of the rear end 182 of the cap body 170 .

[0096] refer to Fig.12 In one embodiment, the second vent plug 124 is disposed in the chamber 172 of the cap body 170 , wherein the first vent plug 122 is disposed between the second vent plug 124 and the front end 180 of the cap body 170 .

[0097] By including a first vent plug 122 upstream of a second vent plug 124 having a carboxymethylcellulose additive, the cap 120 of the present disclosure reduces diffusion rates by introducing a porous material ahead of the carboxymethylcellulose additive plug, thereby limiting analyte bias due to interaction of plasma ions with the carboxymethylcellulose.

[0098] Diffusion through porous materials can be reduced by reducing the porosity or shrinkage of the material and increasing tortuosity. In one embodiment, Fig.11 and 12 As shown, the cap having the first vent plug 122 and the second vent plug 124 having the carboxymethyl cellulose additive operates independently.

[0099] In another embodiment, Fig.11 and 12 The cap shown including the first vent plug 122 and the second vent plug 124 having the carboxymethyl cellulose additive can be combined with a cap body 70 that defines a first chamber 72 having a first diameter D1, a second chamber 74 having a second diameter D2, and a third chamber 76 having a third diameter D3, as shown in FIG. Figure 4 Both embodiments provide the advantageous result of reducing the rate at which analyte bias occurs in samples sealed with a carboxymethyl cellulose porous plug.

[0100] refer to Fig.13In another embodiment, the cap 220 of the present disclosure includes a first vent plug 222 containing a carboxymethyl cellulose additive and a second vent plug 224 containing a carboxymethyl cellulose additive.

[0101] Carboxymethylcellulose is a "self-sealing" additive that swells when it comes in contact with liquid. When this additive is placed in a porous material (particularly a hydrophobic material), it allows air to escape before swelling shut when the liquid reaches the carboxymethylcellulose. This prevents liquid from escaping the collection chamber of the biological fluid collection device. Carboxymethylcellulose can cause analyte bias (usually Ca) in small blood samples (<5 mL). 2+ 、Na + , K + ).

[0102] If a membrane with carboxymethylcellulose additive is exposed to blood or related fluids, it can significantly bias results for analytes in blood at high surface area contact area to volume ratios. Ion exchange between the carboxymethylcellulose additive and ions in plasma can lead to erroneous results.

[0103] In one embodiment, the cap 220 of the present disclosure limits analyte bias due to the interaction of plasma ions with carboxymethyl cellulose by reducing the contact area between blood and the carboxymethyl cellulose additive, such as reducing the radius.

[0104] In one embodiment, the cap 220 of the present disclosure limits analyte bias due to the interaction of plasma ions with carboxymethyl cellulose by increasing the path length between the blood and the carboxymethyl cellulose additive, such as by a certain path length.

[0105] The cap 220 of the present disclosure reduces the rate at which the offset ions can travel away from the carboxymethylcellulose source into the blood (ie, the measurement sample). The cap 220 of the present disclosure is particularly useful in small volumes of blood (<5 ml), where the carboxymethylcellulose additive may significantly affect ion concentrations.

[0106] refer to Fig.13 , the cap 220 includes a cap body 270, a first vent plug 222, and a second vent plug 224. In one embodiment, the cap body 270 defines a first chamber 272 having a first diameter D1, a second chamber 274 having a second diameter D2, and a pair of third chambers 276 having a third diameter D3. In one embodiment, the second chamber 274 is located between the first chamber 272 and the third chamber 276. In one embodiment, the second diameter D2 is smaller than the first diameter D1. In one embodiment, the second diameter D2 is smaller than the third diameter D3.

[0107] By reducing the diameter of the second chamber 274, the cap 220 of the present disclosure limits analyte bias due to the interaction of plasma ions with the carboxymethylcellulose by reducing the contact area between the blood and the carboxymethylcellulose additive, eg, reducing the radius.

[0108] refer to Fig.13 In one embodiment, the second chamber 274 includes a first channel 277, a second channel 278, and a third channel 279. In one embodiment, the first third chamber in each third chamber 276 is connected to the first chamber 272 via the first channel 277 and the second channel 278, and the second third chamber in each third chamber 276 is connected to the first chamber 272 via the first channel 277 and the third channel 279.

[0109] By having a second chamber 274 that extends a certain path length between the first chamber 272 and the third chamber 276 by including a first channel 277, a second channel 278 and a third channel 279, the cap 220 of the present disclosure limits analyte deviation caused by the interaction of plasma ions with carboxymethyl cellulose by increasing the path length between the blood and the carboxymethyl cellulose additive, for example, by a certain path length.

[0110] In one embodiment, the first vent plug 222 is disposed in a first third chamber of each third chamber 276. In one embodiment, the first vent plug 222 includes a carboxymethyl cellulose additive. In one embodiment, the second vent plug 224 is disposed in a second third chamber of each third chamber 276. In one embodiment, the second vent plug 224 includes a carboxymethyl cellulose additive.

[0111] The first vent plug 222 and the second vent plug 224 allow air to pass therethrough and prevent the blood sample from passing therethrough. In one embodiment, the first vent plug 222 is a porous plug. In one embodiment, the second vent plug 224 is a porous plug.

[0112] The first vent plug 222 and the second vent plug 224 are constructed to allow air to pass through the cap 220 while preventing the blood sample from passing through the cap 220, and may include a hydrophobic filter. The first vent plug 222 and the second vent plug 224 each have a selected resistance to air passage, which can be used to finely control the filling rate of the passage 28. By changing the porosity of the plug, the speed of air flowing out of the cap 220 can be controlled, thereby controlling the speed at which the blood sample flows into the collection module 10.

[0113] In one embodiment, the present disclosure provides a cap that limits analyte bias due to the interaction of plasma ions with carboxymethyl cellulose by reducing the contact area between blood and the carboxymethyl cellulose additive, such as reducing the radius.

[0114] In one embodiment, the present disclosure provides a cap that limits analyte bias due to interaction of plasma ions with carboxymethyl cellulose by increasing the path length between blood and the carboxymethyl cellulose additive, such as by a certain path length.

[0115] In one embodiment, the present disclosure provides a cap that reduces diffusion rate by introducing a porous material in front of a carboxymethyl cellulose additive plug, thereby limiting analyte bias due to the interaction of plasma ions with the carboxymethyl cellulose.

[0116] The cap of the present disclosure reduces the rate at which the offset ions may travel away from the carboxymethylcellulose source into the blood (ie, the measurement sample). The cap of the present disclosure is particularly interesting in small amounts of blood (<5 ml), where the carboxymethylcellulose additive may significantly affect ion concentrations.

[0117] Although the present disclosure is described as having an exemplary design, the present disclosure can be further modified in the spirit and scope of the present disclosure. Therefore, the present application is intended to cover any changes, uses or adaptations of the present disclosure using its general principles. In addition, the present application is intended to cover deviations from the present disclosure within the known or customary scope in the field to which the present disclosure belongs and within the limits of the appended claims.

Claims

1. A cap for a biological fluid collection device, comprising: a cap body defining a chamber having an opening at a front end and an opening at a rear end; as well as A vent plug is provided outside the cavity of the cap body and covers an opening at a rear end of the cavity, the vent plug containing a carboxymethyl cellulose additive.

2. The cap according to claim 1, wherein The chamber of the cap body is a first chamber having a first diameter, and the cap body further defines a second chamber having a second diameter and a third chamber having a third diameter, the second chamber being arranged between the first chamber and the third chamber, and wherein the vent plug is arranged on the third chamber.

3. The cap according to claim 2, wherein The second diameter is smaller than the first diameter, and wherein the second diameter is smaller than the third diameter.

4. The cap according to claim 2, wherein The first diameter is smaller than the third diameter.

5. The cap according to claim 2, wherein The first diameter is 1.016 mm, the second diameter is 0.4 mm, and the third diameter is 1.5 mm.

6. The cap according to claim 2, wherein The length of the second chamber is 1.6 mm, and the length of the third chamber is 3.5 mm.

7. The cap according to claim 2, wherein The first cavity is adjacent to a front end of the cap body, and the third cavity is adjacent to a rear end of the cap body.

8. The cap according to claim 1, wherein The vent plug allows air to pass therethrough and prevents the blood sample from passing therethrough.

9. The cap according to claim 1, wherein The vent plug is a porous plug.

10. The cap of claim 1, further comprising a second vent plug disposed in the chamber.

11. A biological fluid collection device, comprising: blood collection tubes; a collection module, the collection module being disposed in the blood collection tube, the collection module comprising a first end, a second end, and a passage extending between the first end and the second end; as well as The cap of claim 1 , attached to the second end of the collection module in the blood collection tube.

12. A cap for a biological fluid collection device, the cap comprising: A cap body, the cap body defining: front end, a rear end, the rear end being opposite to the front end, a first chamber adjacent to the front end, a second chamber in fluid communication with the first chamber, and a pair of third chambers in fluid communication with the second chamber; a first vent plug disposed in a first third chamber of the pair of third chambers of the cap body; and A second vent plug is disposed in a second third chamber of the pair of third chambers of the cap body, wherein each of the first vent plug and the second vent plug includes a carboxymethyl cellulose additive.

13. The cap according to claim 12, wherein The second chamber is located between the first chamber and the pair of third chambers.

14. The cap according to claim 12, wherein The first chamber has a first diameter and the second chamber has a second diameter, and wherein the second diameter is smaller than the first diameter.

15. The cap according to claim 14, wherein The pair of third chambers each define a third diameter, and wherein the second diameter is smaller than the third diameter.

16. The cap of claim 12, wherein: The cap body further defines a first channel extending from the first chamber, a second channel extending from the first channel to the second chamber, and a third channel extending from the first channel to the third chamber.

17. The cap according to claim 16, wherein The first channel is generally perpendicular to the second channel and the third channel.

18. The cap of claim 16, wherein The second channel is substantially parallel to the third channel.

19. A biological fluid collection device, comprising: blood collection tubes; a collection module, the collection module being disposed in the blood collection tube, the collection module comprising a first end, a second end, and a passage extending between the first end and the second end; as well as The cap of claim 12, attached to the second end of the collection module in the blood collection tube.